nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—POR—Doxorubicin—peripheral nervous system neoplasm	0.247	0.317	CbGbCtD
Nitrofurantoin—ABCG2—Topotecan—peripheral nervous system neoplasm	0.168	0.215	CbGbCtD
Nitrofurantoin—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.116	0.149	CbGbCtD
Nitrofurantoin—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0716	0.0919	CbGbCtD
Nitrofurantoin—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0668	0.0857	CbGbCtD
Nitrofurantoin—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0656	0.0842	CbGbCtD
Nitrofurantoin—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0448	0.0574	CbGbCtD
Nitrofurantoin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000303	0.00137	CcSEcCtD
Nitrofurantoin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000303	0.00137	CcSEcCtD
Nitrofurantoin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000303	0.00137	CcSEcCtD
Nitrofurantoin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000303	0.00137	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000301	0.00137	CcSEcCtD
Nitrofurantoin—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.00136	CcSEcCtD
Nitrofurantoin—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000298	0.00135	CcSEcCtD
Nitrofurantoin—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000298	0.00135	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.000297	0.00135	CcSEcCtD
Nitrofurantoin—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000293	0.00133	CcSEcCtD
Nitrofurantoin—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000292	0.00132	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.00132	CcSEcCtD
Nitrofurantoin—Chills—Etoposide—peripheral nervous system neoplasm	0.000286	0.0013	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000285	0.00129	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000284	0.00129	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000284	0.00129	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000282	0.00128	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000282	0.00128	CcSEcCtD
Nitrofurantoin—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000282	0.00128	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000281	0.00128	CcSEcCtD
Nitrofurantoin—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.00028	0.00127	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00028	0.00127	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000278	0.00126	CcSEcCtD
Nitrofurantoin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000277	0.00126	CcSEcCtD
Nitrofurantoin—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000277	0.00125	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.00125	CcSEcCtD
Nitrofurantoin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000275	0.00125	CcSEcCtD
Nitrofurantoin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000275	0.00125	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.000274	0.00124	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000274	0.00124	CcSEcCtD
Nitrofurantoin—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000273	0.00124	CcSEcCtD
Nitrofurantoin—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000272	0.00123	CcSEcCtD
Nitrofurantoin—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.000271	0.00123	CcSEcCtD
Nitrofurantoin—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000271	0.00123	CcSEcCtD
Nitrofurantoin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000271	0.00123	CcSEcCtD
Nitrofurantoin—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000266	0.00121	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000264	0.0012	CcSEcCtD
Nitrofurantoin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000264	0.0012	CcSEcCtD
Nitrofurantoin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000262	0.00119	CcSEcCtD
Nitrofurantoin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000262	0.00119	CcSEcCtD
Nitrofurantoin—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000261	0.00118	CcSEcCtD
Nitrofurantoin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000259	0.00117	CcSEcCtD
Nitrofurantoin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000259	0.00117	CcSEcCtD
Nitrofurantoin—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.00117	CcSEcCtD
Nitrofurantoin—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000258	0.00117	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000258	0.00117	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000257	0.00117	CcSEcCtD
Nitrofurantoin—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000256	0.00116	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000256	0.00116	CcSEcCtD
Nitrofurantoin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000255	0.00116	CcSEcCtD
Nitrofurantoin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000255	0.00116	CcSEcCtD
Nitrofurantoin—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000255	0.00116	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000255	0.00116	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.00115	CcSEcCtD
Nitrofurantoin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000253	0.00115	CcSEcCtD
Nitrofurantoin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000253	0.00115	CcSEcCtD
Nitrofurantoin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000252	0.00114	CcSEcCtD
Nitrofurantoin—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.00114	CcSEcCtD
Nitrofurantoin—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000251	0.00114	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00025	0.00114	CcSEcCtD
Nitrofurantoin—Malaise—Etoposide—peripheral nervous system neoplasm	0.00025	0.00114	CcSEcCtD
Nitrofurantoin—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000249	0.00113	CcSEcCtD
Nitrofurantoin—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000248	0.00113	CcSEcCtD
Nitrofurantoin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000248	0.00113	CcSEcCtD
Nitrofurantoin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000247	0.00112	CcSEcCtD
Nitrofurantoin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000247	0.00112	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000247	0.00112	CcSEcCtD
Nitrofurantoin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000245	0.00111	CcSEcCtD
Nitrofurantoin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000243	0.0011	CcSEcCtD
Nitrofurantoin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000243	0.0011	CcSEcCtD
Nitrofurantoin—Rash—Topotecan—peripheral nervous system neoplasm	0.000243	0.0011	CcSEcCtD
Nitrofurantoin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000243	0.0011	CcSEcCtD
Nitrofurantoin—Cough—Etoposide—peripheral nervous system neoplasm	0.000242	0.0011	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000242	0.0011	CcSEcCtD
Nitrofurantoin—Headache—Topotecan—peripheral nervous system neoplasm	0.000242	0.0011	CcSEcCtD
Nitrofurantoin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000241	0.0011	CcSEcCtD
Nitrofurantoin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000241	0.0011	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000241	0.0011	CcSEcCtD
Nitrofurantoin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00024	0.00109	CcSEcCtD
Nitrofurantoin—Headache—Tretinoin—peripheral nervous system neoplasm	0.00024	0.00109	CcSEcCtD
Nitrofurantoin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00024	0.00109	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000239	0.00108	CcSEcCtD
Nitrofurantoin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000239	0.00108	CcSEcCtD
Nitrofurantoin—Rash—Melphalan—peripheral nervous system neoplasm	0.000238	0.00108	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000237	0.00108	CcSEcCtD
Nitrofurantoin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000236	0.00107	CcSEcCtD
Nitrofurantoin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000236	0.00107	CcSEcCtD
Nitrofurantoin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000233	0.00106	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000233	0.00106	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000231	0.00105	CcSEcCtD
Nitrofurantoin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000229	0.00104	CcSEcCtD
Nitrofurantoin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000229	0.00104	CcSEcCtD
Nitrofurantoin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000229	0.00104	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000229	0.00104	CcSEcCtD
Nitrofurantoin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000228	0.00104	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000228	0.00103	CcSEcCtD
Nitrofurantoin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000227	0.00103	CcSEcCtD
Nitrofurantoin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000227	0.00103	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000226	0.00103	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000225	0.00102	CcSEcCtD
Nitrofurantoin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000225	0.00102	CcSEcCtD
Nitrofurantoin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000224	0.00102	CcSEcCtD
Nitrofurantoin—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000223	0.00101	CcSEcCtD
Nitrofurantoin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000222	0.00101	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000222	0.00101	CcSEcCtD
Nitrofurantoin—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000221	0.001	CcSEcCtD
Nitrofurantoin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000221	0.001	CcSEcCtD
Nitrofurantoin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000221	0.001	CcSEcCtD
Nitrofurantoin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00022	0.001	CcSEcCtD
Nitrofurantoin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000216	0.000979	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000976	CcSEcCtD
Nitrofurantoin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000215	0.000975	CcSEcCtD
Nitrofurantoin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000214	0.000971	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000214	0.00097	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000213	0.000968	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000956	CcSEcCtD
Nitrofurantoin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000208	0.000944	CcSEcCtD
Nitrofurantoin—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000937	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000206	0.000934	CcSEcCtD
Nitrofurantoin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000928	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000204	0.000924	CcSEcCtD
Nitrofurantoin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000203	0.000923	CcSEcCtD
Nitrofurantoin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000202	0.000916	CcSEcCtD
Nitrofurantoin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000201	0.000913	CcSEcCtD
Nitrofurantoin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000201	0.00091	CcSEcCtD
Nitrofurantoin—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000903	CcSEcCtD
Nitrofurantoin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000199	0.000903	CcSEcCtD
Nitrofurantoin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000199	0.000901	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000895	CcSEcCtD
Nitrofurantoin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000197	0.000895	CcSEcCtD
Nitrofurantoin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000197	0.000893	CcSEcCtD
Nitrofurantoin—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000888	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000196	0.000887	CcSEcCtD
Nitrofurantoin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000195	0.000887	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000885	CcSEcCtD
Nitrofurantoin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000194	0.000879	CcSEcCtD
Nitrofurantoin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.00087	CcSEcCtD
Nitrofurantoin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000191	0.000868	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000187	0.000847	CcSEcCtD
Nitrofurantoin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000186	0.000843	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000843	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000185	0.00084	CcSEcCtD
Nitrofurantoin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000185	0.000839	CcSEcCtD
Nitrofurantoin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000184	0.000837	CcSEcCtD
Nitrofurantoin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000836	CcSEcCtD
Nitrofurantoin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000183	0.00083	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000828	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000182	0.000826	CcSEcCtD
Nitrofurantoin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.000825	CcSEcCtD
Nitrofurantoin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000821	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000819	CcSEcCtD
Nitrofurantoin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000179	0.000812	CcSEcCtD
Nitrofurantoin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000179	0.000812	CcSEcCtD
Nitrofurantoin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000811	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000807	CcSEcCtD
Nitrofurantoin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000178	0.000806	CcSEcCtD
Nitrofurantoin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000177	0.000805	CcSEcCtD
Nitrofurantoin—Rash—Vincristine—peripheral nervous system neoplasm	0.000176	0.0008	CcSEcCtD
Nitrofurantoin—Headache—Vincristine—peripheral nervous system neoplasm	0.000175	0.000795	CcSEcCtD
Nitrofurantoin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.000782	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00078	CcSEcCtD
Nitrofurantoin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000169	0.000767	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000766	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000167	0.000757	CcSEcCtD
Nitrofurantoin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000166	0.000753	CcSEcCtD
Nitrofurantoin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.00075	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000746	CcSEcCtD
Nitrofurantoin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000162	0.000737	CcSEcCtD
Nitrofurantoin—Chills—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000727	CcSEcCtD
Nitrofurantoin—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000716	CcSEcCtD
Nitrofurantoin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000157	0.000713	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000709	CcSEcCtD
Nitrofurantoin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000156	0.000707	CcSEcCtD
Nitrofurantoin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000155	0.000703	CcSEcCtD
Nitrofurantoin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000695	CcSEcCtD
Nitrofurantoin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00015	0.000679	CcSEcCtD
Nitrofurantoin—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000673	CcSEcCtD
Nitrofurantoin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000147	0.000666	CcSEcCtD
Nitrofurantoin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000663	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000655	CcSEcCtD
Nitrofurantoin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000144	0.000653	CcSEcCtD
Nitrofurantoin—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000652	CcSEcCtD
Nitrofurantoin—Rash—Etoposide—peripheral nervous system neoplasm	0.000143	0.000648	CcSEcCtD
Nitrofurantoin—Headache—Etoposide—peripheral nervous system neoplasm	0.000142	0.000644	CcSEcCtD
Nitrofurantoin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000643	CcSEcCtD
Nitrofurantoin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000636	CcSEcCtD
Nitrofurantoin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000634	CcSEcCtD
Nitrofurantoin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000632	CcSEcCtD
Nitrofurantoin—Cough—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000616	CcSEcCtD
Nitrofurantoin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000135	0.00061	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000606	CcSEcCtD
Nitrofurantoin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000604	CcSEcCtD
Nitrofurantoin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000601	CcSEcCtD
Nitrofurantoin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000601	CcSEcCtD
Nitrofurantoin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000594	CcSEcCtD
Nitrofurantoin—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000589	CcSEcCtD
Nitrofurantoin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000587	CcSEcCtD
Nitrofurantoin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000584	CcSEcCtD
Nitrofurantoin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000581	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000576	CcSEcCtD
Nitrofurantoin—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00057	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000564	CcSEcCtD
Nitrofurantoin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000556	CcSEcCtD
Nitrofurantoin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000556	CcSEcCtD
Nitrofurantoin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000549	CcSEcCtD
Nitrofurantoin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000549	CcSEcCtD
Nitrofurantoin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000537	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000533	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000525	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000522	CcSEcCtD
Nitrofurantoin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000517	CcSEcCtD
Nitrofurantoin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000513	CcSEcCtD
Nitrofurantoin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000512	CcSEcCtD
Nitrofurantoin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000508	CcSEcCtD
Nitrofurantoin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000507	CcSEcCtD
Nitrofurantoin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000501	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000497	CcSEcCtD
Nitrofurantoin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000493	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000486	CcSEcCtD
Nitrofurantoin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000479	CcSEcCtD
Nitrofurantoin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000475	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000475	CcSEcCtD
Nitrofurantoin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000474	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000471	CcSEcCtD
Nitrofurantoin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000469	CcSEcCtD
Nitrofurantoin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000463	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00046	CcSEcCtD
Nitrofurantoin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000456	CcSEcCtD
Nitrofurantoin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000455	CcSEcCtD
Nitrofurantoin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000455	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.68e-05	0.000439	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	9.61e-05	0.000436	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.35e-05	0.000424	CcSEcCtD
Nitrofurantoin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.29e-05	0.000421	CcSEcCtD
Nitrofurantoin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	9.29e-05	0.000421	CcSEcCtD
Nitrofurantoin—Asthenia—Epirubicin—peripheral nervous system neoplasm	9.11e-05	0.000413	CcSEcCtD
Nitrofurantoin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.69e-05	0.000394	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000393	CcSEcCtD
Nitrofurantoin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.43e-05	0.000382	CcSEcCtD
Nitrofurantoin—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000381	CcSEcCtD
Nitrofurantoin—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000366	CcSEcCtD
Nitrofurantoin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.04e-05	0.000365	CcSEcCtD
Nitrofurantoin—Rash—Epirubicin—peripheral nervous system neoplasm	8e-05	0.000363	CcSEcCtD
Nitrofurantoin—Headache—Epirubicin—peripheral nervous system neoplasm	7.95e-05	0.000361	CcSEcCtD
Nitrofurantoin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.77e-05	0.000352	CcSEcCtD
Nitrofurantoin—Nausea—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.000342	CcSEcCtD
Nitrofurantoin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000339	CcSEcCtD
Nitrofurantoin—Rash—Doxorubicin—peripheral nervous system neoplasm	7.41e-05	0.000336	CcSEcCtD
Nitrofurantoin—Headache—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000334	CcSEcCtD
Nitrofurantoin—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.98e-05	0.000317	CcSEcCtD
